Summary
GlobalData's clinical trial report, “Tinnitus Global Clinical Trials Review, H1, 2016" provides an overview of Tinnitus clinical trials scenario. This report provides top line data relating to the clinical trials on Tinnitus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Merz GmbH & Co. KGaA
Auris Medical Holding AG
Medpace Holdings, Inc.
KYORIN Holdings, Inc.
Dr. Willmar Schwabe GmbH & Co. KG
Autifony Therapeutics Limited
Otonomy, Inc.
Novotech Asia Korea Co Limited
Advanced Clinical, LLC
Abbott Laboratories
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Tinnitus to Ear Nose Throat Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Tinnitus to Ear Nose Throat Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Tinnitus Therapeutics Clinical Trials 28
Prominent Drugs 30
Latest Clinical Trials News on Tinnitus 31
Mar 30, 2016: Auris Medical Completes Enrollment of TACTT2 Phase 3 Trial of AM-101 in Acute Inner Ear Tinnitus 31
Clinical Trial Profile Snapshots 32
Appendix 72
Abbreviations 72
Definitions 72
Research Methodology 73
Secondary Research 73
About GlobalData 74
Contact Us 74
Disclaimer 74
Source 75
List of Tables
Tinnitus Therapeutics, Global, Clinical Trials by Region, 2016* 6
Tinnitus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
Tinnitus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Tinnitus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
Tinnitus Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
Tinnitus Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
Tinnitus Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 13
Tinnitus Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14
Proportion of Tinnitus to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2016* 15
Tinnitus Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
Tinnitus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
Proportion of Tinnitus to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2016* 18
Tinnitus Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
Tinnitus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
Tinnitus Therapeutics, Global, Clinical Trials by Phase, 2016* 21
Tinnitus Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22
Tinnitus Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
Tinnitus Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
Tinnitus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
Tinnitus Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26
Tinnitus Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27
Tinnitus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29
Tinnitus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30
List of Figures
Tinnitus Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Tinnitus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Tinnitus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Tinnitus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10
Tinnitus Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
Tinnitus Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
Tinnitus Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 13
Proportion of Tinnitus to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2016* 15
Tinnitus Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
Tinnitus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
Proportion of Tinnitus to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2016* 18
Tinnitus Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
Tinnitus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
Tinnitus Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21
Tinnitus Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22
Tinnitus Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
Tinnitus Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
Tinnitus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
Tinnitus Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26
Tinnitus Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27
Tinnitus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
Tinnitus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30
GlobalData Methodology 73
